Compared to methylprednisolone, topical doses of ultra low-dose tacrolimus, an immunosuppressive medication, is equally effective and is associated with fewer hypertensive side effects in treating ocular symptoms associated with graft-versus-host-disease, according to a study in Ophthalmology. Read more and read the study abstract.
Tacrolimus effective in treating ocular graft-versus-host-disease
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
